Which innovative pricing strategy did Addgene, a nonprofit plasmid repository, use to make CRISPR technology widely available to scientists?

The 2020 Nobel Prize-winning CRISPR gene-editing technology revolutionized scientific research and medical treatments. However, the pricing strategy for CRISPR-based products and therapies has sparked debate in the scientific community. This poll tests your knowledge about how this groundbreaking technology was commercialized and the unique pricing strategies that helped make it accessible to researchers worldwide.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Tiered pricing based on institution size (charging large pharmaceutical companies more than academic labs)
A flat $65 fee per plasmid (DNA fragment) regardless of commercial potential, dramatically undercutting traditional biotech licensing models
Free distribution with mandatory data sharing requirements for all research results
Subscription-based access with unlimited CRISPR component orders for an annual fee